Financials
- Market Capitalization 1.47 B
- Employee 749
- Founded 1987
- CEO John C. Jacobs
- Website www.novavax.com
- Headquarter Delaware, United States
- FIGI BBG000NVSBL7
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
2.6
市销率
1.04
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2187 | LBRX LB Pharmaceuticals Inc - Common Stock | 48.64 USD | +1.57% | +3.42% | +38.42% | +156.00% | 1.57 B USD | ||
| 2189 | INVA Innoviva, Inc. - Common Stock | 20.98 USD | +0.10% | -0.38% | -3.58% | +17.73% | 1.52 B USD | ||
| 2200 | ABSI Absci Corporation - Common Stock | 8.78 USD | -6.79% | -9.58% | +24.01% | +255.47% | 1.51 B USD | ||
| 2208 | REPL Replimune Group, Inc. - Common Stock | 15.82 USD | +1.41% | +7.40% | +201.33% | +195.15% | 1.49 B USD |